Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gonadal Disorders”

5,933 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 5,933 results

Testing effectiveness (Phase 2)Study completedNCT00091182
What this trial is testing

Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment

Who this might be right for
Childhood Central Nervous System Germ Cell TumorChildhood Extragonadal Germ Cell TumorChildhood Hepatoblastoma+23 more
National Cancer Institute (NCI) 180
Not applicableStudy completedNCT03187327
What this trial is testing

Feasibility of Opportunistic Salpingectomy at the Time of Vaginal Hysterectomy for Benign Pathology

Who this might be right for
SalpingectomyHysterectomy
Hospices Civils de Lyon 69
Not applicableLooking for participantsNCT05761561
What this trial is testing

Trial of Exercise and Lifestyle for Women With Ovarian and Endometrial Cancer

Who this might be right for
Ovarian Cancer
Yale University 200
Large-scale testing (Phase 3)Study completedNCT00068861
What this trial is testing

Treatment of Infertility in Women With Polycystic Ovary Syndrome

Who this might be right for
Polycystic Ovary SyndromeInfertilityPregnancy
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 678
Testing effectiveness (Phase 2)Study completedNCT06608186
What this trial is testing

Can Drospirenone be Used to Prevent LH Surge in Controlled Ovarian Stimulation in PCOS?!

Who this might be right for
PCOS (Polycystic Ovary Syndrome)
Ahmed Saad 50
Not applicableUnknownNCT05679362
What this trial is testing

Online Brief CBT Intervention for Women With PCOS

Who this might be right for
PCOS (Polycystic Ovary Syndrome) of Bilateral OvariesDepression, AnxietySelf Esteem
Erasmus Medical Center 222
Large-scale testing (Phase 3)UnknownNCT01654146
What this trial is testing

ICON8: Weekly Chemotherapy in Ovarian Cancer

Who this might be right for
Ovarian Cancer
Medical Research Council 1,485
Early research (Phase 1)Study completedNCT02914470
What this trial is testing

Carboplatin-cyclophosphamide Combined With Atezolizumab

Who this might be right for
Breast CancerCervix CancerOvarian Cancer+1 more
The Netherlands Cancer Institute 12
Large-scale testing (Phase 3)Study completedNCT02504541
What this trial is testing

Subcutaneous Testosterone Enanthate Safety in Adult Men Diagnosed With Hypogonadism

Who this might be right for
Hypogonadism
Antares Pharma Inc. 133
Not applicableUnknownNCT04800705
What this trial is testing

Levels of Selected Macroelements in Premature Ovarian Insufficiency

Who this might be right for
Premature Ovarian Failure
Cengiz Gokcek Women's and Children's Hospital 140
Post-approval studies (Phase 4)UnknownNCT00378729
What this trial is testing

Surgical Ovarian Drilling Versus Hormonal Treatment for Infertility Associated to PolyCystic Ovaries Syndrome (PCOS)

Who this might be right for
Polycystic Ovary Syndrome
Assistance Publique - Hôpitaux de Paris 252
Early research (Phase 1)Looking for participantsNCT05316129
What this trial is testing

Infusion of Autologous T Cells Engineered to Target FSH Receptor in Recurrent Ovarian Cancer

Who this might be right for
Ovarian Cancer
H. Lee Moffitt Cancer Center and Research Institute 10
Large-scale testing (Phase 3)Study completedNCT00467870
What this trial is testing

Long-term Safety Study of Intramuscular Injections of 750 mg and 1000 mg Testosterone Undecanoate in Hypogonadal Men

Who this might be right for
HypogonadismPrimary HypogonadismSecondary Hypogonadism
Endo USA Inc., a Keenova Therapeutics Company 531
Testing effectiveness (Phase 2)Study completedNCT00003670
What this trial is testing

Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Metastatic Refractory Ovarian Cancer or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerPrimary Peritoneal Cavity Cancer
Eli Lilly and Company
Testing effectiveness (Phase 2)Study completedNCT01583322
What this trial is testing

Vargatef in Addition to First Line Chemotherapy With Interval Debulking Surgery in Patients With Ovarian Cancer

Who this might be right for
Ovarian Cancer
ARCAGY/ GINECO GROUP 188
Post-approval studies (Phase 4)Study completedNCT02866786
What this trial is testing

The Effects of OCP and Metformin on Clinical, Hormonal, Metabolic and Ultrasonographic Characteristics in PCOS

Who this might be right for
Polycystic Ovary Syndrome
S.C.B. Medical College and Hospital 101
Testing effectiveness (Phase 2)Study completedNCT02178670
What this trial is testing

Safety and Effectivity Immunotherapy to Treat Ovarian Cancer With Cancer Stem Cells Vaccine

Who this might be right for
Neoplasms,Ovarian
Fuda Cancer Hospital, Guangzhou 40
Early research (Phase 1)Study completedNCT00616941
What this trial is testing

Phase 1 Study of NY-ESO-1 Overlapping Peptides in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Epithelial Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer
Ludwig Institute for Cancer Research 28
Early research (Phase 1)Study completedNCT03629756
What this trial is testing

Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced Malignancies

Who this might be right for
Non-small Cell Lung CancerSquamous Cell Carcinoma of the Head and NeckBreast Cancer+9 more
Arcus Biosciences, Inc. 48
Not applicableStudy completedNCT00043472
What this trial is testing

Removal of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk

Who this might be right for
Breast CancerOvarian Cancer
National Cancer Institute (NCI) 40
Next Page